Unknown OBSERVATIONAL NCT04770974

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

Definition of Tumor Bio-markers and Physical-spectroscopic Differences Between Healthy Urothelial Tissue Healthy and Urothelial Cancer

Sponsor: Careggi Hospital

Conditions Bladder Cancer Urothelial Carcinoma Urothelial Carcinoma Bladder Urothelial Carcinoma in Situ Urothelial Neoplasm

Interventions Biomarkers and proteomics

Updated 5 times since 2021 Last updated: May 6, 2022 Started: Dec 10, 2020 Primary completion: Dec 7, 2022 Completion: Dec 7, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04770974, this observational or N/A phase trial focuses on Bladder Cancer and Urothelial Carcinoma and remains ongoing. Sponsored by Careggi Hospital, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting
Mar 2021 — Jun 2022 [monthly]

Recruiting

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Careggi Hospital
Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy
University of Florence
University of Milano Bicocca

Data source: University of Florence

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Florence, Italy